Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis

por Gao, Chao, Peng, Cuiting, Shi, Yaojie, You, Xinyu, Ran, Kai, Xiong, Lu, Ye, Ting-hong, Zhang, Lidan, Wang, Ningyu, Zhu, Yongxia, Liu, Kun, Zuo, Weiqiong, Yu, Luoting, Wei, Yuquan
Publicado 2016

Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer

por Song, Xuejiao, Gao, Tiantao, Wang, Ningyu, Feng, Qiang, You, Xinyu, Ye, Tinghong, Lei, Qian, Zhu, Yongxia, Xiong, Menghua, Xia, Yong, Yang, Fangfang, Shi, Yaojie, Wei, Yuquan, Zhang, Lidan, Yu, Luoting
Publicado 2016

Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer

por Song, Xuejiao, Gao, Tiantao, Wang, Ningyu, Feng, Qiang, You, Xinyu, Ye, Tinghong, Lei, Qian, Zhu, Yongxia, Xiong, Menghua, Xia, Yong, Yang, Fangfang, Shi, Yaojie, Wei, Yuquan, Zhang, Lidan, Yu, Luoting
Publicado 2016